FDA Official Peter Marks Resigns Over Vaccine Policy Disputes

Marks' resignation, effective April 5, follows clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine misinformation and public health priorities.

Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research, has resigned after being pressured to step down by Trump administration officials.
Marks criticized HHS Secretary Robert F. Kennedy Jr. for undermining vaccine confidence and promoting misinformation, calling it a danger to public health and safety.
Industry leaders and public health experts have expressed alarm, warning that Marks' departure could weaken FDA leadership and erode scientific standards.
Marks, a key figure in Operation Warp Speed and the approval of 22 gene therapies, was widely praised for his contributions to regulatory innovation and public health.
His resignation comes as vaccine skepticism and declining vaccination rates fuel concerns about public health, highlighted by a recent measles outbreak in the U.S.

GEN

Genetic Literacy Project